Rezultati

eNauka >  Rezultati >  Identifying Trial-Eligible High- and High-Intermediate Risk Patients with Diffuse Large B-Cell Lymphoma Using Prognostic Models: A Real-Life Comparative Analysis of IPI, aaIPI and NCCN-IPI from Danish Study Group
Naziv: Identifying Trial-Eligible High- and High-Intermediate Risk Patients with Diffuse Large B-Cell Lymphoma Using Prognostic Models: A Real-Life Comparative Analysis of IPI, aaIPI and NCCN-IPI from Danish Study Group
Autori: Jeličić, Jelena ; Juul-Jensen, Karen; Bukumirić, Zoran  ; Simonsen, Mikkel Runason; Clausen, Michael Roost; Al Mashhadi, Ahmed; Pedersen, Robert Schou; Poulsen, Christian Bjorn; Ortved Gang, Anne; Brown, Peter;
El Galaly, Tarec Christoffer Christoffer; Stauffer Larsen, Thomas;
Godina: 2024
Publikacija: Blood (66th Annual Meeting of the American Society of Hematology (ASH), Dec 7-10, 2024, Orlando, USA)
ISSN: 0006-4971 Blood Pretraži identifikator
Izdavač: [New York] : Elsevier
Tip rezultata: Konferencijski rad
Kolacija: vol. 144 br. Supplement 1 str. 650-651
DOI: 10.1182/blood-2024-201672
WoS-ID: 001412638600050
URI: https://enauka.gov.rs/handle/123456789/986048
URL: https://ashpublications.org/blood/article/144/Supplement%201/650/530678/Identifying-Trial-Eligible-High-and-High
Izvor metapodataka: (Preuzeto iz Nasi u WoS)
M-kategorija: 
Mp kategorija će biti prikazana naknadno.

1
WEB OF SCIENCETM
Alt metrika
Dimensions
Unpaywall

Google ScholarTM

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.